European Lifestars Awards - Celebrating Life Science Leaders’ Post

𝗧𝗼𝗽 𝟮𝟬 𝗥&𝗗 𝗦𝗽𝗲𝗻𝗱𝗶𝗻𝗴 𝗕𝗶𝗼𝗽𝗵𝗮𝗿𝗺𝗮 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗼𝗳 𝟮𝟬𝟮𝟰 Driven by constant innovation, biopharma companies are steadfastly acclimatizing to the needs of the future by leveraging cutting-edge technologies in Research and development! The global Top 20 pharmaceutical industry spent $148B in 2022 and grew to $180B in 2023, with Merck & Co., having the highest R&D expenditure of $30.53B, followed by Roche ($15.73) and Johnson & Johnson (15.08)  Happy Reading and Stay Tuned! PharmaShots, Merck, Roche, Johnson & Johnson, Novartis, AstraZeneca, Pfizer Eli Lilly and Company, Bristol Myers Squibb, GSK, AbbVie, Sanofi, Boehringer Ingelheim, Bayer, Gilead Sciences, Takeda, Moderna, Novo Nordisk, Amgen, Regeneron, Vertex Pharmaceuticals #researchanddevelopment #pharmaceuticalindustry #healthcaresector #innovativetherapeutics #top20pharmaceuticalcompanies #randd #expenditure #merckandco. #roche #johnsonandjohnson #randdspending #biopharmacompanies #pharmashotsreport https://lnkd.in/g3cJxPqY

Heading to Boston for Future Pharma and pumped to learn more about how pharma is driving change in the healthcare landscape. We're actively partnering with top pharma companies to shorten the distance between brands and their target consumers - so if you're interested in learning how Wheel can support your consumer activation strategy, let's connect! #futurepharma #pharmamarketing #patientcentric #pharma #consumerhealth

What are the factors that drive pharma R&D Productivity? Which pharma companies have done it best? Catenion has been systematically analyzing R&D Productivity for over 10 years. Now, our team has conducted a longitudinal study to answer these key questions, outlined by Catenion's Senior Partner Markus Thunecke. 💡A must-watch for everyone in the biopharma industry. Explore the in-depth report here: https://lnkd.in/gnhMzesy Companies featured: Novo Nordisk, AstraZeneca, Eli Lilly and Company, Novartis, Roche, Eisai US, Daiichi Sankyo, Inc., Pfizer, Sanofi, UCB, Merck KGaA, Darmstadt, Germany Bayer, Otsuka Pharmaceutical Co., Ltd., Takeda, Biogen, Gilead Sciences, AbbVie, Merck, Bristol Myers Squibb, GSK, Amgen, Johnson & Johnson, Astellas Pharma #Catenion #BiophamaConsulting #BiopharmaInnovation #RnDProductivity

Here's Catenion's 10-year longitudinal study systematically clustering top biopharma companies into six performance phenotypes and dissecting patterns, key factors that positively influence R&D productivity. Key Takeaways: ♦ Creativity and innovation are easier to orchestrate in smaller units with less bureaucracy and high individual accountability ♦ Going deep vs broad: Having a solid TA focus and thinking well in advance about the ability to create spin off indications should not be neglected ♦ Focusing on key high-value assets, and ideally, having a 'pipeline in a product' is the best thing for R&D productivity ♦ Striking a balance between relying on core internal strengths for organic growth and leveraging external innovation through deals and M&As needs to be achieved You can read the full report here: https://lnkd.in/gnhMzesy

Thanks Sanofi for putting your trust on us PharmaTrace . Now after NVIDIA elite startup program, now another big milestone which shows our dedication and perseverance to put our marks within healthcare and Pharma ecosystems. We don’t talk we do! Danke merci chokran Dm me or contact us for our various portfolio in #competitiveintelligene #trackandtrace #serialization #blockchain #AI #management

Looking forward to attending CPHI Milan this week where I will be talking with suppliers to the #pharmaceutical industry about how the #Energize program can accelerate their #renewableelectricty adoption. On October 8th at 3:15 CET in Hall 6 - 6A28 Mary (Meyer) Poddar Energize program manager and Giulia Usai from founding sponsor GSK will be presenting a case study on how the program has #supplychain #decarbonisation impact. Please come along and learn more about why the program matters to the 24 program sponsors and how you can benefit from the free #renewableenergy education and procurement services. See session summary below. If you are a supplier to Amgen Almirall AstraZeneca Boehringer Ingelheim Bristol Myers Squibb Charles River Laboratories Chiesi Group GSK Haleon Kenvue Johnson & Johnson MSD Merck Group Novartis Novo Nordisk Pfizer Roche Sandoz Sanofi SCHOTT Takeda Teva Pharmaceuticals UCB or a member of PSCI - Pharmaceutical Supply Chain Initiative you automatically qualify for the programme and can register for free here: https://lnkd.in/eWtqTf7Y If you're attending CPHI Milan and would like to discuss how we can support your company’s #decarbonisation journey, feel free to reach out. #Pharma #lifeison #Sustainability #RenewableEnergy #SupplyChain

What are the main dimensions driving successful businesses in Biopharma? Check out Catenion’s learnings from a 10-year longitudinal study on R&D productivity to find out. Get in touch if you want to hear more!

🚀 Top 10 Pharma Companies by Drug Pipeline 🚀 The competition is fierce in the pharma industry, but these companies are leading the charge with the most robust pipelines: Roche Pfizer AstraZeneca Eli Lilly Bristol Myers Squibb Novartis Johnson & Johnson Jiangsu Hengrui Pharmaceuticals Merck & Co. Sanofi 💡 Why Pipeline Analysis Matters: A strong drug pipeline reflects innovation, market leadership, and future growth. Pipeline analysis not only highlights the number of drugs but also gives insight into the therapeutic areas being targeted, the innovation pipeline, and potential blockbusters in the making. Pharma companies with deeper pipelines are better positioned to sustain long-term revenue growth, combat evolving healthcare challenges, and bring life-changing treatments to patients worldwide. 🔍 At the core of pipeline analysis is the ability to anticipate market needs, identify opportunities for expansion, and stay ahead of the curve in an ever-evolving healthcare landscape. Let’s continue to watch how these industry leaders shape the future of medicine! 🌟 #Pharma #DrugPipeline #HealthcareInnovation #Pharmaceuticals #CompetitiveAnalysis #MarketLeadership #FutureOfMedicine #PipelineAnalysis #ClinicalTrials

𝐓𝐨𝐩 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐛𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐂𝐚𝐩 I previously wrote about top medical product companies by market cap. Here is also a look at the top #pharmaceutical companies by market cap 1- Eli Lilly and Company 2- Novo Nordisk 3- Johnson & Johnson and Johnson 4- Merck 5- AbbVie 6- AstraZeneca 7- Roche 8- Novartis 9- Amgen 10- Pfizer 11- Sanofi 12- Vertex Pharmaceuticals 13- Regeneron 14- CSL 15- Gilead Sciences 16- Bristol Myers Squibb 17- Zoetis 18- GSK 19- Merck Group Some of these companies like J&J and Roche have a large medtech/diagnostics divisions, but I included them in pharma category only as majority of their revenue comes from their pharma division. #pharma #marketcap #valuation * Views and ideas are my own. The information that I provide are public and intended to be educational only and are not endorsement or financial advice. I always encourage the readers to do their own research.

📺 𝗧𝗼𝗽 🔟 𝗧𝗩 𝗗𝗿𝘂𝗴 𝗔𝗱 𝗦𝗽𝗲𝗻𝗱𝗲𝗿𝘀 𝗶𝗻 𝟮𝟬𝟮𝟯 💰 👑 TV Drug Ad Spending Crown is for AbbVie, AGAIN! 💸 In 2023, AbbVie reaffirmed its TV drug ad spending dominance, with #Skyrizi leading the charge at a staggering $383.7 million—more than double the previous year's $174.4 million. 💊 #Rinvoq (another product from Abbvie) followed closely, securing second place with a robust $351.1 million, marking a significant leap from 2022's $315.8 million. 🤑 The top 10 pharma DTCs collectively invested a remarkable $1.94 billion in 2023, signaling a substantial increase from 2022's $1.68 billion. 1️⃣ & 2️⃣ AbbVie 3️⃣ Sanofi & Regeneron 4️⃣ Eli Lilly and Company & Boehringer Ingelheim 5️⃣ Lundbeck & Otsuka Pharmaceutical Co., Ltd. 6️⃣ Bristol Myers Squibb 7️⃣ Novo Nordisk 8️⃣ AbbVie 9️⃣ Eli Lilly and Company 🔟 GSK 📚 Source: Fierce Pharma #tvads #top10 #tvadvertising #pharmaindustry #medicine #drugdevelopment